The Lancet Respiratory Medicine
-
1
[News] Unravelling of tuberculosis control in Ukraine
-
2
[Comment] Survival is not the end(point): the second phase of ECPR care
-
3
[Editorial] Lung cancer: sharing progress in an equitable way
-
4
[Spotlight] Solange Peters—improving the odds for lung cancer survival
-
5
[Series] Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies
-
6
[Series] Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges
-
7
[Articles] Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
-
8
[Correspondence] Identifying the residual unmet need in severe asthma
-
9
[Spotlight] Edinburgh Festival Fringe: “Cancer isn't pretty—and neither is opera”
-
10
[Spotlight] A Pox on Fools: The Grifters and Cynics Who Want Us To Reject Vaccines
The Lancet Rheumatology
-
1
[Editorial] Prioritising pain management in inflammatory arthritis
-
2
[Corrections] Correction to Lancet Rheumatol 2026; 8: e539–49
-
3
[News] Research in Brief
-
4
[Articles] Diagnostic accuracy of musculoskeletal ultrasound in suspected polymyalgia rheumatica: a multicentre, cohort study
-
5
[Viewpoint] Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases
-
6
[Comment] Diagnosing polymyalgia rheumatica: rethinking musculoskeletal ultrasound
-
7
[Articles] Derivation, validation, and proposed thresholds of the Lupus Arthritis and Musculoskeletal Disease Activity (LAMDA) instrument: a cohort study
-
8
[Corrections] Correction to Lancet Rheumatol 2026; 8: e336–45
-
9
[Correspondence] Maternal anti-AT1A1 autoantibodies and congenital heart block: findings from a Swedish national cohort
-
10
[Correspondence] Maternal anti-AT1A1 autoantibodies and congenital heart block: findings from a Swedish national cohort – Authors’ reply
eClinicalMedicine
-
1
[Articles] Drug coated balloons versus drug eluting stents for de novo coronary artery disease: a systematic review and meta-analysis of randomised controlled trials
-
2
[Viewpoint] Promoting equitable cancer care: learnings from the development of the Optimal Care Pathway for people living in rural and remote areas with cancer
-
3
[Articles] Sex and disease differences in patients’ diagnostic experiences in autoimmune diseases: an international cross-sectional study
-
4
[News] EUSEM Congress 2026
-
5
[Articles] Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trail
-
6
[Articles] The lancet commission definition of clinical obesity: a multi-cohort cross-sectional analysis from early childhood to older age in seven high-income countries
-
7
[Articles] Associations of digital media use with health, behavioural and developmental outcomes in children and adolescents: an umbrella review and meta-analysis
-
8
[Articles] Overnight metyrapone in mild autonomous cortisol secretion: a single-centre, single-arm, phase 2 trial
-
9
[Viewpoint] The clinical consequences of excessive caution: rethinking how cancer screening policy is made
-
10
[Articles] Outcome at ten years of children born preterm: the EPIPAGE-2 and ELFE cohort studies
The Lancet
-
1
[Department of Error] Department of Error
-
2
[Correspondence] China–Nepal border catastrophic floods: a planetary health alarm
-
3
[Correspondence] Thirlwall, Bier's spots, and the Letby murders
-
4
[Correspondence] Health care criminalised in Italian immigration detention centres
-
5
[Perspectives] Richard Dadd's beguiling art
-
6
[Comment] Tailoring levels of evidence in trials comparing common treatments
-
7
[Comment] Hepatitis C—is discrimination preventing elimination?
-
8
[Correspondence] Prioritising the future of youth is an urgent political choice
-
9
[Perspectives] John Wong: making an impact on population health at scale
-
10
[Comment] 21st century global threats to health are not what you think
The Lancet Child & Adolescent Health
-
1
[Comment] Paediatric liver transplantation: the risk of hepatic artery thrombosis
-
2
[Articles] Outcomes of hepatic artery thrombosis after paediatric liver transplantation (HEPATIC): an international, multicentre, retrospective registry study
-
3
[Reflections] Centring children and adolescents in drug policy development
-
4
[Comment] Growing up with congenital Zika syndrome
-
5
[Articles] Growth patterns of children with congenital Zika syndrome in Brazil: a matched-cohort study
-
6
[Articles] Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, pha
-
7
[Review] Mental health and urinary incontinence in childhood
-
8
[Reflections] Protecting children from meningitis: maintaining momentum
-
9
[Articles] Global reference values for daily steps in preschool children (SUNRISE): a cross-sectional analysis from 44 countries
-
10
[Articles] Health service use of young people after mental health admission far from home: a retrospective cohort study in England
The Lancet Diabetes & Endocrinology
-
1
[Corrections] Correction to Lancet Diabetes Endocrinol 2026; 14: 894–902
-
2
[Correspondence] Multidisciplinary care of pituitary adenomas
-
3
[Review] Hashimoto's thyroiditis: two decades on
-
4
[Articles] Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial
-
5
[Comment] IL-2 and immunoregulatory therapies in newly diagnosed type 1 diabetes
-
6
[Comment] What Mauritius teaches us about diabetes surveillance
-
7
[Articles] Trends in prevalence of type 2 diabetes and intermediate hyperglycaemia in Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study
-
8
[Editorial] Safeguarding paediatric metabolic health
-
9
[Review] Diabetes and the role of primary care: a global perspective
-
10
[Personal View] Disease modification outcomes in type 2 diabetes: a modified Delphi
The Lancet Gastroenterology & Hepatology
-
1
[Comment] THR-β agonism in MASH: expanding the evidence to Asia
-
2
[Articles] Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
-
3
[Review] Strategies to develop therapeutic cancer vaccines for pancreatic cancer
-
4
[Articles] Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study
-
5
[Review] Pain management in chronic pancreatitis: beyond opioids
-
6
[Articles] Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
-
7
[Comment] Lessons from the European LiverScreen and Chinese LiverHealth projects
-
8
[Articles] Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
-
9
[Comment] Decompensation unmasks renal susceptibility in cirrhosis
-
10
[Articles] Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study
The Lancet Global Health
-
1
[Correspondence] Accountability for pandemic financing decisions
-
2
[Comment] Expression of concern: Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries
-
3
[Articles] 2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis
-
4
[Articles] Artificial intelligence-supported diabetic retinopathy screening in Tanzania: a randomised controlled trial
-
5
[Correspondence] Refining global models for large-scale food fortification
-
6
[Correspondence] Refining global models for large-scale food fortification
-
7
[Articles] Informing an mpox stockpile investment case: epidemiological modelling and cost–benefit analysis
-
8
[Correspondence] Interpreting the lifetime risk of maternal near miss
-
9
[Comment] Expression of concern—Effect of Brazil’s national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20–24 years: a population-based study
-
10
[Articles] Hospital-based prevalence of culture-confirmed melioidosis among high-risk patients in India, 2023–25: a multicentre prospective study
The Lancet Healthy Longevity
-
1
[Articles] Prevalence, management, and outcomes of urinary tract infections in older adults living in care homes versus older adults living outside care homes in the UK: a propensity score-matched case–control analysis
-
2
[Editorial] Making dementia clinical trials more representative
-
3
[Articles] Social connection and intrinsic capacity in later life across the USA, England, Europe, China, and Japan: a harmonised multicohort longitudinal study
-
4
[Comment] Hearing loss, hearing aids, and longevity: from association to intervention
-
5
[Articles] Hearing loss, hearing-aid use, and mortality risk: individual participant data meta-analysis of population-based studies from Australia, Iceland, and the USA and a replication study from Norway
-
6
[Comment] Healthy ageing for all? Socioeconomic inequalities in intrinsic capacity across generations
-
7
[Articles] Cohort trends in intrinsic capacity in Europe: a population-based longitudinal study
-
8
[Articles] RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial
-
9
[Articles] Effect of pre-existing dementia on cancer-specific and all-cause mortality in patients with cancer in Denmark: a population-based cohort study
-
10
[Personal View] Sarcopenia as a manifestation of systemic energetic failure with ageing